- Research works
- 7 ▼ 96% vs 2013–17
- Citations
- 275 41.0 per fractional work
- Top-10% rate
- 100.0% record average 16.5%
- Open access
- 91% world 28%
Not ranked overall: Aratana Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Aratana Therapeutics (United States) publish most on?
By volume in 2022–2025: Sirtuins and Resveratrol in Medicine, PARP inhibition in cancer therapy and RNA modifications and cancer.
- 1 Sirtuins and Resveratrol in Medicine Geriatrics and Gerontology 0 works
- 2 PARP inhibition in cancer therapy Oncology 0 works
- 3 RNA modifications and cancer Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Aratana Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 96% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Leawood
- American Academy of Family Physicians
- Swanson Center
- Society of Teachers of Family Medicine
- American Medical Society for Sports Medicine
- North American Primary Care Research Group
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.